BASIC VOLUME. Elements of Drug Dependence Treatment

Similar documents
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph

ADHD & Addictions -What We Know

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

THE STATE OF MEDICINE IN ADDICTION RECOVERY

Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents

Understanding Addiction: Why Can t Those Affected Just Say No?

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

VOLUME B. Elements of Psychological Treatment

BASIC VOLUME. Elements of Drug Dependence Treatment

Opioid dependence: Detoxification

Long term treatment for opioid dependence Antagonist therapy

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Depression & Alcohol

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain

Treatment Approaches for Drug Addiction

The future of pharmacological treatment.

Medication-Assisted Treatment. What Is It and Why Do We Use It?

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

Unit II Problem 7 Pharmacology: Substance Abuse, Dependence and Addiction

6B / Boswell, Grant and Slutske Day 2 August 14, 2008

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction

^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

WELCOME TO THE CRACKS IN THE ICE WEBINAR SERIES

Adult 65D-30 Intervention ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

OPIOIDS AND NON-CANCER PAIN

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Substance Use Disorders

Treatment Team Approaches in Substance Abuse Treatment

ASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Opiate Use Disorder and Opiate Overdose

How Addiction Affects the Brain: The Neuroscience of Compulsive Behavior

Opioid Use Disorder Treatment Initiation in Diverse Settings

substance use and mental disorders: one, the other, or both?

List of coping skills for addiction

Opioid Overdose Epidemic A Crises and Opportunity

Mary Ann Ferguson,Pharmacist St Josephs Health Care Concurrent Disorders Inpatient Unit

Medication-Assisted Treatment (MAT) Overview

Chapter 13. Types of Drugs and Their Effects. Unit 5: Drug Use and Abuse. Key Terms. What Are Drugs?

NALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018

Pharmacotherapy for Substance Use Disorders

Psychotropic Drugs Critical Thinking - KEY

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Dr. Solomon Derese. Department of Chemistry University of Nairobi

ROSC & MAT II: Opioid Treatment Services

7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER ELEVEN CHAPTER OUTLINE. Substance Use Disorders. Oltmanns and Emery

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Overview of Psychoactive Drug use

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Guidance for naltrexone prescribing

Neuroscience of Addiction

Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version

Thaddeus Ulzen MD FRCP(C)FAPA FCGP Professor & Chair, Department of Psychiatry and Behavioral Medicine, Associate Dean for Academic Affairs

Goal: To learn about and evaluate the value of various biologically-based methods in the treatment of different forms of psychopathology

Effective Treatment: Doing the Right Thing, In the Right Way. Terrence D Walton, MSW, ICADC

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

AODA RECOVERY. How to support those in recovery, and those not yet ready to commit

C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS

Workshop Objectives. 2) Participants will learn about the current FDA-approved pharmacotherapies for alcohol and opioid dependence.

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

HIV and alcohol use: why is risk reduction in alcohol use important in HIV care?

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved

SUD Requirements. Proprietary

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

VIVITROL (naltrexone for extended-release injectable suspension) A µ-opioid Receptor Antagonist

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Youth, Opioid Use and Treatment Options. CPSO MMT Providers Conference Dr. Sharon Cirone MD FCFPC November 2016

Addiction. Counselling. Short Course STUDY GUIDE

Alcohol: Its effects on the brain and implications for future treatment. Dr Mark Daglish

SECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario

HARM REDUCTION & TREATMENT. Devin Reaves MSW

Pain and Addiction. Edward Jouney, DO Department of Psychiatry

Module II Opioids 101 Opiate Opioid

Ken Winters, Ph.D. Department of Psychiatry University of Minnesota Midwest Conference on Problem Gambling August 11, 2004

Mental Health Awareness BY ALISHBA, KOPINA, TASMIN, AND ZEESHAAN.

ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA

Substance Abuse Level of Care Criteria

ASAM CRITERIA 3 rd Edition

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.

Intro to Concurrent Disorders

Referral to Treatment: Utilizing the ASAM Criteria

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond

The Nervous System Mark Stanford, Ph.D.

The Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth

SUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic

Transcription:

BASIC VOLUME Elements of Drug Dependence Treatment

Module 3 Principles of CBT and relapse prevention strategies Introduction to Cognitive Behavioural Therapy Basics of pharmacological treatment

Workshop 2 Basics of pharmacological treatment

Training Objectives At the end of this workshop you will be able to: Explain basic principles and concepts of drug use and dependence Determine the specific role of pharmacotherapy for overdose, as well as withdrawal, maintenance and relapse prevention treatments Identify the setting and stages for the use of medicationassisted approaches to substance use Discuss the different options which exist for medicationassisted therapies, and with which substances they are effective 4

What is addiction?

What is addiction? Advances in science have revolutionized our fundamental views of drug use, dependence and addiction 6

What is addiction? Addiction is a brain disease, characterised by: Compulsive behaviour Continued use of drugs despite negative consequences Persistent changes in the brain s structure and function 7

Addiction as a brain disease Addiction is a chronic, often relapsing brain disease that causes compulsive drug seeking and use, despite harmful consequences to the addicted individual and to those around him or her Although the initial decision to take drugs is voluntary for most people, the brain changes that occur over time challenge an addicted person s self control and hamper his or her ability to resist intense impulses to take drugs 8

Drug addiction as a chronic medical condition Addiction is similar to other chronic (c/c), relapsing diseases like diabetes, asthma/heart disease Drug addiction can be managed and treated successfully As with other c/c diseases, it is not uncommon for a person to relapse and begin using drugs again Relapse, does not signal treatment failure it indicates that treatment should be reinstated or adjusted to help the individual regain control and recover 9

Understanding the reward system

Dopamine: basis for motivation, reward and addiction 11

Dopamine & some more.. Dopamine is only PART of the story Scientific research has shown that other neurotransmitter systems are also affected: Serotonin (regulates mood, sleep, etc.) Glutamate (regulates learning and memory, etc.) 12

Drugs and the brain

Why can t people just stop drug use? When people first try drugs, it is usually a voluntary decision but after using the drug for a while, it is no longer voluntary! So why can t people stop? 14

Why can t people stop? Because their brans have been re-wired by drug use 15

Why can t people stop? Brain pathways are affected by drugs 16

Drug use changes brain Prolonged drug use changes the brain in fundamental ways that reinforce drug taking and lead to dependence and/or addiction Drug use changes both the structure of the brain and its functionality Exposure to some drugs of abuse can change the structure of neurons in the brain Repeated drug exposure also changes brain function Decrease in Dopamine transporter activity, e.g. Methamphetamine These changes are difficult to undo and may last a long time. 17

Psychoactive drugs Psychoactive drugs are generally defined as substances that alter: Mood Cognition (thoughts) Behaviour 18

Drug use and health

Drug use and health Patients with drug use disorders: Often have multiple health and social problems Expect doctors to ask and provide information about alcohol and drug issues failure to inquire may lead to medical malpractice in some situations 20

Important terminology Harmful use Physical dependence vs. addiction Psychological craving Tolerance Withdrawal symptoms Neurotransmitters and receptors 21

Psychological craving Psychological craving is a strong desire or urge to use drugs. Cravings are most apparent during drug withdrawal. 22

Tolerance A state in which a person no longer responds to a drug as they did before, and a higher dose is required to achieve the same effect. 23

Withdrawal A period during which somebody dependent on a drug or other addictive substance reduces their use or stops taking it, causing the person to experience painful or uncomfortable symptoms. OR A person takes a similar substance in order to avoid experiencing the effects described above. 24

Withdrawal When a drug is removed, physical and/or mental disturbances may occur, including: Physical symptoms Emotional problems Cognitive and attention deficits Aggressive behavior Hallucinations Convulsions Death 25

Rationale for the treatment of drug use disorders Treatment works Behavioural therapies can engage people in treatment, modify their attitudes and behaviours related to drug abuse and increase their life skills Medications are available to treat opioid, alcohol and tobacco addiction, while others are on the horizon In addition, behavioural therapies can enhance the effectiveness of these medications and can help people stay in treatment longer 26

Rationale for the use of medication Treatment of acute intoxication Prevent and treatment of withdrawal symptoms (detoxification) Reduce craving and compulsion to use Normalize disrupted physiological functions Prevent relapse Create opportunities for longer term psychosocial treatment 27

Goals of pharmacological management of withdrawal To provide withdrawal that is humane and protects the patient's dignity To provide a safe withdrawal from the drug(s) of dependence and enable the patient to become drug free To prepare the patient for ongoing treatment of his or her substance dependence 28

Pharmacological treatment: summary There are medications available to treat drug use disorders caused by different types of drugs Pharmacological treatment should be a part of a comprehensive treatment plan that also includes psychosocial interventions Pharmacological treatment only (e.g., detoxification) is not always enough to treat drug use disorders or addiction 29

Pharmacotherapies There are medications available to support treatment of drug use disorders: Alcohol dependence Benzodiazepines and symptomatic treatment: Thiamine & multivitamins, Antiemetic, Analgesia (e.g., paracetamol), Antidiarrhoeal Opioids dependence Long acting opioids agonists: Methadone, Buprenorphine Antagonists: Naltrexone Psychostimulant dependence: promising medication ongoing research 30

Questions

Wrap-up What is drug dependence? What is addition? What common characteristics do they share with other chronic diseases? Why people cannot easily stop drug use? How drugs affect human body? What is the rationale for the use of medications in the treatment of drug use disorders?

Post-assessment

What is your take-away? What was the most meaningful to you in this training? What will you take away with you? What did you enjoy the most? How will you use this information? What skill(s) do you think you will begin to practice in your work? What would you like to share in closing?

Thank you for your time! End of module 3